SG
EDVA

StoneX Group’s Endovia Health Sciences, Inc. EDVA Stock Holding History

StoneX Group’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.35K Buy
+7,038
New +$7.29K ﹤0.01% 1410
2023
Q4 		– Sell
-82
Closed -$7.76K – 697
2023
Q3 		$7.76K Buy
+82
New +$10.6K ﹤0.01% 594
2023
Q1 		– Sell
-89
Closed -$13.7K – 789
2022
Q4 		$13.7K Buy
+89
New +$15.6K ﹤0.01% 539

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

StoneX Group's EDVA Position: Q2 2026 in Review

StoneX Group opened a new position in Endovia Health Sciences, Inc. (EDVA) in Q2 2026: 7,038 shares worth $5.35K. The stake represents ﹤0.01% of the portfolio and ranks #1410 among its holdings. This is a return to the name: StoneX Group previously reported a position in EDVA as recently as Q3 2023.

StoneX Group first reported a position in EDVA in Q4 2022 and has held it in 3 quarters since. The position peaked at $13.7K in Q4 2022. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • StoneX Group held 7,038 shares of Endovia Health Sciences, Inc. worth $5.35K as of Q2 2026.
  • Endovia Health Sciences, Inc. was a new StoneX Group position in Q2 2026.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1410 holding.
  • StoneX Group first reported a position in Endovia Health Sciences, Inc. in Q4 2022 and has held it in 3 quarters since.
  • StoneX Group's Endovia Health Sciences, Inc. position peaked at $13.7K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.